Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
NCT ID: NCT01424033
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01424033
Study Brief: A Clinical Trial for CTD-ILD Treatment
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
N-Acetylcysteine This is an open label trial, all patient will be entered into one treatment arm. N-Acetylcysteine: 600mg by mouth, three times daily for 12 months None None 3 5 0 5 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cancer recurrence SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders None View
Death SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Hospitalization, tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Other Events(If Any):